Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Hexin Zongdan Medical Technology Co., Ltd. (Hexin Zondan) is a prominent Chinese medical technology company specializing in clinical mass spectrometry and in vitro diagnostics (IVD). A subsidiary of the publicly traded Guangzhou Hexin Instrument, the company focuses on the development, manufacturing, and commercialization of triple quadrupole LC-MS/MS systems and associated reagent kits. Their core product portfolio includes the AST-6000 mass spectrometer and automated sample preparation modules designed for high-throughput clinical environments. Hexin Zondan provides specialized diagnostic solutions for therapeutic drug monitoring, nutritional assessment, and metabolic screening, particularly for analytes such as vitamins and immunosuppressants. By integrating advanced analytical instrumentation with standardized clinical workflows, the company serves as a key player in the modernization of clinical laboratory testing across China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hexin Zondan.